Adagene Shares 2011-2026 | ADAG

Annual Shares Adagene

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
59 M	56.3 M	54.7 M	54.1 M	50 M	16 M	15.2 M	15.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
59 M	15.2 M	40.1 M

Quarterly Shares Adagene

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	54.6 M	-	-	-	16.6 M	-	-	-	15.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
54.6 M	15.2 M	28.8 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	46.7 M	$ 21.69	1.31 %	$ 1.01 B	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	7.35 M	$ 0.91	1.61 %	$ 6.69 M	China
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	166 M	$ 22.3	1.55 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	18.8 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	244 M	$ 102.42	-2.88 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	3.13 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	107 M	$ 4.13	1.1 %	$ 442 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 23.34	0.32 %	$ 2.97 B	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	266 M	$ 1.43	-0.69 %	$ 381 M	Britain
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	44.3 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
Esperion Therapeutics ESPR	208 M	$ 1.92	0.54 %	$ 399 M	USA
BioDelivery Sciences International BDSI	99.3 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	1.42 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
bluebird bio BLUE	110 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	521 K	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	66.8 M	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	12.2 M	$ 1.09	1.89 %	$ 13.3 M	USA
Cabaletta Bio CABA	100 M	$ 2.95	-0.17 %	$ 296 M	USA
Cara Therapeutics CARA	7.42 M	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	136 M	-	-	$ 35.4 M	USA